Biotinylated Human B7-H7 / HHLA2 Protein, Fc, Avitag™ (MALS verified) | B77-H82F3-200ug

Biotinylated Human B7-H7 / HHLA2 Protein, Fc, Avitag™ (MALS verified) | B77-H82F3-200ug| Gentaur Distribution US, UK & Europe

B7-H7 (HHLA2) is a newly identified B7 family member that regulates human T-cell functions. B7-H7 was previously known as human endogenous retrovirus-H long terminal repeat associating 2 (HHLA2) with unidentified function. Recently, B7-H7 has been identified as a specific ligand for human CD28H. The B7-H7-CD28H pathway strongly promoted CD4+ T-cell proliferation and cytokine production via an AKT-dependent signaling cascade in the presence of TCR signaling, suggesting B7-H7 comprises a new co-stimulatory pathway. The first IgV domain of B7-H7, which presumably binds to a putative receptor, shows the highest homology to other B7 family members.

Source: Biotinylated Human B7-H7 Protein, Fc, Avitag (B77-H82F3) is expressed from human 293 cells (HEK293). It contains AA Ile 23 - Asn 344 (Accession # Q9UM44-1).

Format: Powder.

Tag: C-Fc & C-Avi.

Expression System: HEK293.

Expression Region: Ile 23 - Asn 344.

Conjugate: Biotin-labeled.

Molecular Weight: 65.1 kDa.

Characteristics: This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 65.1 kDa. The protein migrates as 70-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 95%.

Buffer: 51 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl.

Storage Conditions: -20℃.

Shipping Conditions: RT